Gut Microbes

Article	Citations
Upregulation of Lactobacillus spp . in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects	209
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma	186
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	184
Microbiota-directed biotherapeutics: considerations for quality and functional assessment	168
Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease	140
The effects of gut microbiota on appetite regulation and the underlying mechanisms	133
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	127
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	101
Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries	97
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	96
GPR120 promotes neutrophil control of intestinal bacterial infection	86
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	84
Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment	81
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	80
Campylobacter jejuni benefits from the bile salt deoxycholate under low-oxygen condition in a PldA dependent manner	75
Effects of Prevotella copri on insulin, gut microbiota and bile acids	75
E. coli Common pili promote the fitness and virulence of a hybrid aEPEC/ExPEC strain within diverse host environments	75
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients	73
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	72
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response	72
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	72
Gut microbiota links to serum ferritin and cognition	69
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	67
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	66
Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control	65

Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restor	64
Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesis	63
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury	63
Mucosal washes are useful for sampling intestinal mucus-associated microbiota despite low biomass	63
Increased dietary protein stimulates amino acid catabolism via the gut microbiota and secondary bile acid production	62
The immune response modulated by inoculation of commensal bacteria at birth impacts the gut microbiota and prevents Salmonella colonization	62
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	61
From intestinal colonization to systemic infections: Candida albicans translocation and dissemination	60
Host-mycobiome metabolic interactions in health and disease	59
MlrA, a MerR family regulator in Vibrio cholerae , senses the anaerobic signal in the small intestine of the host to promote bacterial intestinal colonization	59
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	57
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	57
Salmonella enterica subsp. II serovar 4,5,12:a:- may cause gastroenteritis infections in humans	57
Modeling spatial interaction networks of the gut microbiota	57
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	56
Loss-of-function SLC30A2 mutants are associated with gut dysbiosis and alterations in intestinal gene expression in preterm infants	55
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery	54
Helicobacter pylori PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survival	52
Detection of Klebsiella pneumoniae human gut carriage: a comparison of culture, qPCR, and whole metagenomic sequencing methods	52
Effect of diet on the evolution of gut commensal bacteria	51
The neonatal gut microbiome and global health	51
Gut microbiota and microbial metabolites for osteoporosis	51
EspH interacts with the host active Bcr related (ABR) protein to suppress RhoGTPases	51
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus	50
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	50
Genomic island-encoded LmiA regulates acid resistance and biofilm formation in enterohemorrhagic Escherichia coli O157:H7	50
Muropeptides and muropeptide transporters impact on host immune response	50
The IBS bug-pain connection	49
Heterogeneous associations of gut microbiota with Crohn’s disease activity	49
Gut microbiota depletion delays somatic peripheral nerve development and impairs neuromuscular junction maturation	49
Correction	49
Rural environment reduces allergic inflammation by modulating the gut microbiota	48
Incremental increases in physiological fluid shear progressively alter pathogenic phenotypes and gene expression in multidrug resistant Salmonella	48
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretor	48
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	48
How important are fatty acids in human health and can they be used in treating diseases?	48
The importance of the gut microbiome in the pathogenesis and transmission of SARS-CoV-2	47
Dynamic associations between the respiratory tract and gut antibiotic resistome of patients with COVID-19 and its prediction power for disease severity	47
Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet	47
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	46
Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation	45
Divergence of gut bacteria through the selection of genomic variants implicated in the metabolism of sugars, amino acids, and purines by small extracellular vesicles in milk	45
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	45
Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy	44
Heterologous expression and antimicrobial potential of class II bacteriocins	44
Microbiome 2.0: lessons from the 2024 Gut Microbiota for Health World Summit	44
In vitro adhesion, pilus expression, and in vivo amelioration of antibiotic-induced microbiota disturbance by Bifidobacterium	44
Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature	43
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	43
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	43

Weizmannia coagulans BCF-01: a novel gastrogenic probiotic for Helicobacter pylori infection control	43
Short-term mucosal disruption enables colibactin-producing E. coli to cause long-term perturbation of colonic homeostasis	43
Host miR-129-5p reverses effects of ginsenoside Rg1 on morphine reward possibly mediated by changes in B. vulgatus and serotonin metabolism in hippocampus	42
A foundational approach to culture and analyze malnourished organoids	42
Abnormalities in gut virome signatures linked with cognitive impairment in older adults	41
Mechanisms of gut bacterial metabolism of dietary polyphenols into bioactive compounds	41
Controlled infection with cryopreserved human hookworm induces CTLA-4 expression on Tregs and upregulates tryptophan metabolism	41
Unexpected vulnerability of Enterococcus faecium to polymyxin B under anaerobic condition	40
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury	40
Gut microbiota CLA and IL-35 induction in macrophages through Gαq/11-mediated STAT1/4 pathway: an animal-based study	40
Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice	40
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	39
Oxygen concentration modulates colibactin production	39
Methodological challenges in neonatal microbiome research	39
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response	39
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	38
Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model	38
Detecting host responses to microbial stimulation using primary epithelial organoids	38
Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease	38
Sialic acid-based probiotic intervention in lactating mothers improves the neonatal gut microbiota and immune responses by regulating sialylated milk oligosaccharide synthesis via the gut–breast axis	37
Unveiling Candida albicans intestinal carriage in healthy volunteers: the role of micro- and mycobiota, diet, host genetics and immune response	37
Modulation of chronic obstructive pulmonary disease progression by antioxidant metabolites from Pediococcus pentosaceus : enhancing gut probiotics abundance and the tryp	37
Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum	37
Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease	37
Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges	37
Bacteriophages from treatment-naïve type 2 diabetes individuals drive an inflammatory response in human co-cultures of dendritic cells and T cells	36
Mechanisms of intestinal dysbiosis: new insights into tuft cell functions	36
Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients	36
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	36
Fecal virus-like particles are sufficient to reduce necrotizing enterocolitis	35
Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer	35
The early life exposome and autism risk: a role for the maternal microbiome?	35
Synergism of Fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation	35
Candida tropicalis -derived vitamin B3 exerts protective effects against intestinal inflammation by promoting IL-17A/IL-22-dependent epithelial barrier function	34
Prevention and cure of murine C. difficile infection by a Lachnospiraceae strain	34
Dysfunctional mucus structure in cystic fibrosis increases vulnerability to colibactin-mediated DNA adducts in the colon mucosa	34
A gut feeling of statin	34
ChiA: a major player in the virulence of Crohn’s disease-associated adherent and invasive Escherichia coli (AIEC)	34
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study	34
Normalization of short-chain fatty acid concentration by bacterial count of stool samples improves discrimination between eubiotic and dysbiotic gut microbiota caused by Clostridioides	33
Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats	33
Technical versus biological variability in a synthetic human gut community	33
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation	33
Unique Pakistani gut microbiota highlights population-specific microbiota signatures of type 2 diabetes mellitus	32
The role of microbial indole metabolites in tumor	32
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	32
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	32
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity	32
Immune evasion and persistence in enteric bacterial pathogens	31
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	31
Dietary Isoflavones Alter Gut Microbiota and Lipopolysaccharide Biosynthesis to Reduce Inflammation	31
Epidemiological and microbiome associations of Clostridioides difficile carriage in infancy and early childhood	31
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer	31
Butyrate reduces adherent-invasive E. coli -evoked disruption of epithelial mitochondrial morphology and barrier function: involvement of free fatty acid receptor 3	31
Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome	31
Modulation of Alzheimer’s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a	31
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation	31
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	30
Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice	30
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	30
Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis	30
Gut microbiota: a non-target victim of pesticide-induced toxicity	30
Novel strain of Pseudoruminococcus massiliensis possesses traits important in gut adaptation and host-microbe interactions	30
The unforeseen intracellular lifestyle of Enterococcus faecalis in hepatocytes	30
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	30
Mucus, commensals, and the immune system	30
Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations	29
Intestinal bacteria and colorectal cancer: etiology and treatment	29
Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis	29
Intestinal group 1 innate lymphoid cells drive macrophage-induced inflammation and endocrine defects in obesity and promote insulinemia	29
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation	29
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	29
Distinctive patterns of sulfide- and butyrate-metabolizing bacteria after bariatric surgery: potential implications for colorectal cancer risk	29
Hyperbaric oxygen augments susceptibility to C. difficile infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3	28
Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice	28
Gut-derived β-amyloid: Likely a centerpiece of the gut–brain axis contributing to Alzheimer’s pathogenesis	28
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies	28
Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men	28
Multiomic spatial analysis reveals a distinct mucosa-associated virome	28
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial	28

Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer’s disease progression	28
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells	28
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	28
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	28
Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID	28
Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions	28
Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum -infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellu	27
The influence of the gut microbiome on ovarian aging	27
Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis	27
Microbial-host-isozyme: unveiling a new era in microbiome–host interaction	27
Fecal virome transfer improves proliferation of commensal gut Akkermansia muciniphila and unexpectedly enhances the fertility rate in laboratory mice	27
Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use	26
Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis	26
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	26
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management	26
Lactiplantibacillus plantarum 299v supplementation modulates β-cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats	26
Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway	26
Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review	26
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	26
Functional effects of human milk oligosaccharides (HMOs)	26
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	26
Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils	26
Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics	26
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	25
An observational investigation of the faecal microbiota and metabonome of gastrostomy fed children, on blended and formula diets	25
Phospholipid metabolites of the gut microbiota promote hypoxia-induced intestinal injury via CD1d-dependent γδ T cells	25
Correction	25
Linkage analysis identifies novel genetic modifiers of microbiome traits in families with inflammatory bowel disease	25
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	25
An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation	24
Human colitis-associated colorectal carcinoma progression is accompanied by dysbiosis with enriched pathobionts	24
Gut microbiota mediates the inhibition of lymphopoiesis in dietary-restricted mice by suppressing glycolysis	24
Microbial micronutrient sharing, gut redox balance and keystone taxa as a basis for a new perspective to solutions targeting health from the gut	24
Apyrase decreases phage induction and Shiga toxin release from E. coli O157:H7 and has a protective effect during infection	24
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	24
Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection	24
The cnf1 gene is associated with an expanding Escherichia coli ST131 H 30Rx/C2 subclade and confers a compe	23
A metabolically engineered bacterium controls autoimmunity and inflammation by remodeling the pro-inflammatory microenvironment	23
Metaproteomic assessment of gut microbial and host functional perturbations in Helicobacter pylori -infected patients subjected to an antimicrobial protocol	23
Gut microbiome-driven regulation of sex hormone homeostasis: a potential neuroendocrine connection	23
Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease	23
Bifidobacterium longum subsp. infantis utilizes human milk urea to recycle nitrogen within the infant gut microbiome	23
Akkermansia in the gastrointestinal tract as a modifier of human health	23
Correction	23
Rhodococcus spp. interacts with human norovirus in clinical samples and impairs its replication on human intestinal enteroids	23
Microbial metabolites as modulators of the infant gut microbiome and host-microbial interactions in early life	22
Bifidobacterium infantis utilizes N-acetylglucosamine-containing human milk oligosaccharides as a nitrogen source	22
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	22
Cesarean section induced dysbiosis promotes type 2 immunity but not oxazolone-induced dermatitis in mice	22
The impact of aging-induced gut microbiome dysbiosis on dendritic cells and lung diseases	22
Correction	22
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	22
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?	22
Diet and the gut-lung axis in cystic fibrosis – direct & indirect links	22
Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic	22
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	22
Letter regarding “Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial”	21
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	21
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	21
Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease	21
Alterations in intestinal Archaea composition in pediatric patients with Crohn’s disease based on next-generation sequencing – a pilot study	21
Failure of colonization following gut microbiota transfer exacerbates DSS-induced colitis	21
A novel framework for assessing causal effect of microbiome on health: long-term antibiotic usage as an instrument	21
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era	20
Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure	20
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease	20
More than just a number: the gut microbiota and brain function across the extremes of life	20
Maternal-infant antibiotic resistance genes transference: what do we know?	20
Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in Apc Min/+	20
The role of the early-life gut microbiome in childhood asthma	20
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	19
Molecular serotyping of diarrheagenic Escherichia coli with a MeltArray assay reveals distinct correlation between serotype and pathotype	19
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	19
Gut-bacteria derived membrane vesicles and host metabolic health: a narrative review	19
Indole-3-acetic acid alleviates DSS-induced colitis by promoting the production of R-equol from Bifidobacterium pseudolongum	19
Potential binding modes of the gut bacterial metabolite, 5-hydroxyindole, to the intestinal L-type calcium channels and its impact on the microbiota in rats	19
Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer	19
Correction	19
Prebiotic utilisation provides Lactiplantibacillus plantarum a competitive advantage in vitro , but is not reflected by an increased intes	19
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms	19
Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond	19
Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine	19
Butyrate reduces epithelial barrier dysfunction induced by the foodborne mycotoxin deoxynivalenol in cell monolayers derived from pig jejunum organoids	19
Desulfovibrio vulgaris flagellin exacerbates colorectal cancer through activating LRRC19/TRAF6/TAK1 pathway	19
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	18
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain	18
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	18
Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial	18
Intestinal microbiota modulates neuroinflammatory response and brain injury after neonatal hypoxia-ischemia	18
Correction	18
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	18
Microbial stars: shedding light on gut microbes’ role in insulin resistance and innovative diabetes therapies	18
Meta-analysis identifying gut microbial biomarkers of Qinghai-Tibet Plateau populations and the functionality of microbiota-derived butyrate in high-altitude adaptation	18
Correction	18
Maternal probiotic exposure enhances CD8 T cell protective neonatal immunity and modulates offspring metabolome to control influenza virus infection	18